CD79A and Hypercalcemia: We found that our model generally predicted the correct trends for both immunoglobulins, e.g., downtrend in IgA in response to treatment, and biomarkers related to CRAB (Hypercalcemia, Renal failure, Anemia, and Bone lesions) complications (e.g., calcium, hemoglobin, and creatinine).